Examkin

Question

Difficulty: MediumGynecologic Oncology

A 3636-year-old nulligravid woman with a history of polycystic ovary syndrome (PCOS) and obesity (body mass index 4141) presents with frequent, heavy menstrual bleeding occurring every 1414 to 6060 days. She has not responded to an initial trial of combined oral contraceptives. The patient explicitly states a strong desire to have children in the near future.

Arrange the following steps in the most appropriate chronological sequence for the diagnosis, definitive management, and long-term follow-up of this patient.

  1. 1Perform an in-office endometrial biopsy
  2. 2Confirm a diagnosis of complex atypical hyperplasia
  3. 3Initiate continuous high-dose progestin therapy
  4. 4Perform a repeat endometrial biopsy in 33 to 66 months
  5. 5Recommend a total hysterectomy once childbearing is complete

Answer

The correct sequence is to first perform an in-office endometrial biopsy, which leads to the diagnosis of complex atypical hyperplasia. Because the patient desires fertility, this is followed by initiating continuous high-dose progestin therapy, assessing treatment response with a repeat biopsy in 33 to 66 months, and finally planning a total hysterectomy once childbearing is complete.
This patient has chronic unopposed estrogen exposure due to PCOS and obesity, placing her at high risk for endometrial hyperplasia and cancer. The failure of oral contraceptives to control her bleeding further necessitates a tissue diagnosis. The first step is an endometrial biopsy. Once atypical hyperplasia (endometrial intraepithelial neoplasia) is diagnosed, standard definitive treatment is a total hysterectomy due to the high risk of concurrent or future malignancy. However, for young patients who strongly desire future fertility, a fertility-sparing approach using high-dose progestins (e.g., levonorgestrel intrauterine device or oral megestrol acetate) is the recommended next step. Close surveillance is mandatory, so a repeat endometrial biopsy must be performed in 33 to 66 months to ensure the lesion is regressing. Ultimately, because the risk of disease progression remains high, definitive surgical management (hysterectomy) is indicated immediately after the patient has completed childbearing.

Step-by-Step Solution

1
Identify the patient's risk factors for endometrial malignancy.
The patient has chronic unopposed estrogen exposure due to PCOS and obesity, presenting with abnormal uterine bleeding that failed medical management.
Recognizing these risk factors justifies the need for immediate tissue sampling.
2
Determine the initial diagnostic modality.
An in-office endometrial biopsy is selected as the first step.
Endometrial biopsy is the gold standard initial test to rule out hyperplasia or carcinoma in high-risk patients with abnormal uterine bleeding.
3
Determine the appropriate therapy for the resulting diagnosis while accommodating patient preferences.
High-dose progestin therapy is initiated for the diagnosis of complex atypical hyperplasia.
While hysterectomy is the definitive treatment, progestin therapy is the standard fertility-sparing option for young women desiring future pregnancy.
4
Establish the follow-up and long-term management plan.
Repeat sampling in 33 to 66 months, followed by hysterectomy once childbearing is complete.
Close surveillance is required to ensure the hyperplasia regresses. Long-term definitive surgical management is necessary due to the high recurrence and progression rates.

Key Concept

Management of complex atypical endometrial hyperplasia (endometrial intraepithelial neoplasia) in patients desiring future fertility.
Estimated Time:1m 30s
Rate this question

Topics

Gynecologic Oncology

More questions from this topic